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Abstract
Background and Objective: Understanding the molecular and cellular pathways activated in response to  Plasmodium  falciparum
infection is crucial for the development of  pharmacological intervention to malaria. The present study was designed to evaluate the lipid
components and the oxidative status of erythrocyte obtained from children under 5 years infected with  Plasmodium  falciparum.
Materials and Methods: Parasitemia was assessed prior and after treatment with antimalarial, erythrocyte lipid profile, levels of lipid
peroxidation and antioxidant status (reduced glutathione, GSH; superoxide dismutase, SOD; catalase and glutathione peroxidase, GPx)
were measured. Results: Results  obtained  showed  that in Plasmodium infected erythrocyte, the total phospholipids, cholesterol and
LDL-cholesterol concentrations  were  significantly  elevated  beyond  the normal level. In addition, an upsurge in erythrocyte oxidant
(lipid peroxide) status with a concomitant downregulation of  the antioxidant status (GSH concentration and SOD, catalase and GPx
activities) was observed in  P.  falciparum-infected children. However, following  a three-day treatment with artemisinin combination
drugs, there was a significant reduction in  erythrocyte  phospholipids,  total  cholesterol and LDL-cholesterol concentration as well as
lipid peroxide levels. Significant  augmentation  in  erythrocyte  antioxidant  status  (GSH,  SOD,  catalase and GPx) were also observed
after treatment with antimalarials. Conclusion: This study demonstrated that erythrocyte lipids and oxidative status are usually altered
in  Plasmodium  falciparum-infected children. Thus, monitoring erythrocyte lipid profile and oxidative status could offer a viable diagnostic
strategy in early detection of malaria in children.
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INTRODUCTION
Changes  in  erythrocyte   lipid   composition  and  the
host oxidant-antioxidant status are two critical associated
events involved in the pathogenesis  of  malaria1.  However,
the overriding mechanisms  involved in lipid-antioxidant
dynamics in malaria have not been  fully elucidated. Within
the erythrocytes in the human host, the malaria parasite
undergoes cyclical development. During the intraerythrocytic
stage of the  parasite  development,  about 5-10 merozoites
are produced every 24 h. A corresponding increase in
metabolic activity  with concomitantly membrane turn-over
rate is required to sustain the growing parasite at this stage.
Labaied et al.2 have shown that Plasmodium falciparum
infection induces a six-fold increase erythrocyte phospholipid
content. In order to meet up with its high requirement for
phospholipids, the infected erythrocytes contain phospholipid
synthesizing enzymes3. Thus, potent inhibitors of plasmodial
phospholipid synthesis was previously characterized as
potential target for antimalarial chemotherapy due to its
crucial role to the parasite survival4. 
It is not fully understood why children of African descent
develop severe malaria neither has there been justifiable
reasons for the high mortality rate among African children
who develop malaria5. Therefore, the elucidation of genetic,
biochemical and immunologic factors the pathogenesis of
severe and fatal malaria is a key objective. Several scientific
justifications have been advanced to implicate changes in
redox metabolism in the process. First, oxidative changes are
involved in the host response to malaria. Therefore, plasma
lipid peroxides are usually elevated in malaria infected
children, especially in riboflavin-deficient children6,7.  It has
also been established that lipid peroxidation  is  also  increased
with a corresponding decrease in antioxidant status in
infected erythrocytes compared to non-infected control6. The
involvement of oxygen radicals in the parasite clearance in
both mice and humans have been reported8,9. Drugs, such as;
paracetamol which decrease the production of oxygen radical
have been shown to delay parasite clearance10. Mice with
NADPH oxidase mutant gene unable to produce superoxide
radical were reported to demonstrate a high  susceptibility
and severity to malarial parasite infection compared to their
wild type counterpart11. Taken together, these  observations
among other suggested that derangement in erythrocyte ROS
generation might exacerbate infection. 
The existence of oxidative stress and changes in
erythrocyte lipid profile during acute malarial infection have
been demonstrated in some studies. It is hypothesized that
the developing malarial parasites and the associated increase
in metabolic activities within the erythrocytes coupled with
the   immunologic  induction  of  ROS  production  by  the host
in  response   to  malarial  infection  could  possibly  account
for the  changes  in  the  erythrocyte  lipid  profile  and  the
host antioxidant  status12,13.  This  study  was  undertaken to
evaluate the changes in erythrocyte lipids and the host
oxidant/antioxidant status in  Plasmodium  falciparum
infected children.
MATERIALS AND METHODS
Ethical approval: The study protocol was approved by the
Mother and Child Hospital Akure (MCHA), Research and Ethics
Committee and the Joseph Ayo Babalola University, Research
and Ethics Committee (JABUHE002/2015) and was carried out
in compliance with the tenets of the Helsinki Declaration.
Subjects: The study population consisted  of  children  aged
0-5 years admitted in the acute care unit of the MCHA
between April and June, 2015. The MCHA serves as a WHO
accredited tertiary care referral center for pregnant women,
nursing mothers and children under 5 years for Ondo state
and neighbouring states like Ekiti, Edo, Osun and Kogi (all in
Nigeria).  A finger-prick blood  sample  was obtained from
each subject to prepare thick and thin blood films used to
determine the  presence  or  absence  of  malaria  parasites
and  the  level  of  parasitemia.  Subjects  with  a primary
clinical diagnosis  and positive peripheral blood smear for
Plasmodium  falciparum  were enrolled into the study after a
written signed informed consent form was obtained from
respective parents or guardians as appropriate. The consent
form was written in both English and Yoruba languages and
read to the parents and guardians before appending their
signatures or thumb prints. A signed or thumb printed copy of
the consent form was given to each parent or guardian. 
Subjects with one or more complications of severe
malaria (prostration, coma or respiratory distress) as defined
by Marsh et al.14 were grouped under complicated malaria
subjects while those with acute malaria and severe anaemia
(haemoglobin <5 g dLG1) devoid of other complications of
complicated  malaria were group as acute malaria subjects.
The non-malaria control subjects consisted of asymptomatic
children with no demonstrated Plasmodium  falciparum  in
their peripheral blood smear. Prior to obtaining venous blood
sample from each subject, a brief clinical history was taken to
ascertain their health status. In addition, data on sex, age,
weight and height were also obtained.
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Exclusion criteria: The following categories of  subjects were
excluded in the study, those known to have received blood
transfusion within 3 months prior to the study,  subjects on
any known antimalarial drug or on antioxidant or iron
supplementation therapy. 
Blood collection and plasma preparation: Venous blood
sample (5 mL) was collected by venipuncture on two
occasions (prior to the  administration  of  any antimalarial
drug at the time of hospitalization and after 3 days of
antimalaria treatment) into lithium heparin tubes and
centrifuged at 5000 rpm for 10 min to obtain plasma. The
plasma  was  stored  at  -4EC  until  required for further
analysis. 
Assessment of  blood parasitemia: Giemsa-stained thick and
thin blood films obtained from each subject were analyzed to
determine the number of  parasites per 200 white blood cells.
Slides were considered negative if no parasites were seen in
100 fields on the thick film.
Erythrocyte membrane preparation: Erythrocyte membrane
‘ghosts’ were prepared within 12 h of plasma separation,
essentially as described by Burton et al.15. 
Biochemical analysis:  Erythrocyte  phospholipids content
was estimated by using the method described by Stewart16.
Triglyceride concentration was determined following the
protocol described by Carr et al.17. Total cholesterol
concentration  was  estimated  according   to   the    method
of   Allain   et  al.18  and  HDL-cholesterol  according  to
Warmick et al.19. LDL-cholesterol was evaluated by using
Friedewald’s equation20. Lipid peroxidation was determined by
the method described by Buege and Aust21. Superoxide
dismutase (SOD) activity was determined following the
method of McCord and Fridovich22. Catalase (CAT) and
glutathione peroxidase activities were assayed according to
the  methods described by Aebi23 and Flohé and Günzler24,
respectively. Reduced glutathione (GSH) level was estimated
according to the method of Moron et al.25. 
Statistical analysis: The data obtained are presented as
mean±SEM of  25 determinations. The mean values of control
and test groups were compared by using one-way analysis of
variance (ANOVA) and Duncan Multiple Range Test (DMRT)
performed by using GraphPad Prism software (version 6.05).
The p<0.05 was considered to be significant.
RESULTS
Subject’s characteristics: About 75 children categorized
either   as  normal  (25),  acute  (25)  and  complicated (25)
were enrolled in the study. Subjects with complicated
Plasmodium falciparum malaria were admitted placed on
admission while those with acute malaria were asked to return
after 3 days of antimalaria treatment. About 80 and 92% for
complicated and normal  subjects,  respectively  returned at
day 4 for follow up. Characteristics of the subjects at baseline,
including  sex,  age,  weight and height were as shown in
Table 1. At enrollment, subjects with acute and complicated
malaria had significantly (p<0.5) lower body weight and
height compared with normal subjects. Mean parasitemia
before and after treatment in were significantly (p<0.05)
higher in subjects with complicated malaria compared with
non-complicated malaria subjects (Fig. 1). 
Erythrocyte lipid profile:  Prior to  treatment,  erythrocyte
total phospholipid concentration was significantly (p<0.01)
higher in complicated subjects compared to non-complicated
subjects (Fig. 2a). However, after treatment with antimalarials,
significant (p<0.05) decrease in erythrocyte total phospholipid
content in subjects with complicated malaria compared to the
Table 1: Subjects baseline characteristics 
Characteristics Normal Acute Complicated
Male (%) 58.0 52.00 56.00
Female (%) 42.0 48.00 44.00
Age (months)" 36.0±5.3 38.00±5.0 42.00±7.1
Weight (kg)" 14.8±3.9 13.61±3.3* 12.73±2.5*
Height (cm)" 104.0±38.2 91.40±25.6* 76.20±20.3*
"Values are mean±SEM of 25 determinations. *Significantly different from
normal (p<0.05)
Fig. 1: Mean parasitemia level at baseline
Values are mean±SEM of 25 determinations. *Significantly different
from non-complicated (p<0.05)
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Fig.  2(a-e): (a) Erythrocyte total phospholipids, (b) Total cholesterol, (c) Triglycerides, (d) Low-density lipoprotein (LDL)-
cholesterol and (e) High-density lipoprotein (HDL)-cholesterol concentrations in  Plasmodium  falciparum  infected
children before and after treatment with antimalarial drugs
Results are mean±SEM of 25 determinations. *Significantly different from normal (p<0.05). **Significantly different from normal (p<0.01)
baseline level.  Baseline  total cholesterol concentration in
both non-complicated  and  complicated  malaria  subjects
was significantly  (p<0.01)  higher compared to non-malaria
control subjects (Fig. 2b). Significant  decreases  were
observed in erythrocyte total cholesterol concentration in
both non-complicated and complicated subjects  compared
to   their   respective  baseline  levels by following  treatment
with antimalaria drug (Fig. 2b). Erythrocyte triglycerides
concentration was not significantly different across the
different subject groups before and after treatment (Fig. 2c). 
LDL-cholesterol concentration in both non-complicated and
complicated malaria subjects was significantly (p<0.01) higher
compared to non-malaria control subjects before treatment.
After treatment with antimalarials, erythrocyte LDL-cholesterol
concentration in both non-complicated and complicated
subjects showed significant decrease (p<0.05) compared to
their respective baseline  levels  (Fig.  2d).  HDL-cholesterol
(Fig. 2e) was not significantly different in non-complicated,
complicated and non-malaria control subjects before and after
treatment.
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Fig. 3(a-e): (a) Erythrocyte lipid peroxide level, (b) Reduced glutathione concentration, (c) Superoxide dismutase, (d) Catalase and
(e) Glutathione peroxidase activities in Plasmodium  falciparum  infected children before and after treatment with
antimalarial drugs
Results are mean±SEM of 25 determinations. *Significantly different from normal (p<0.05). **Significantly different from normal (p<0.01)
Antioxidant status: Baseline erythrocyte lipid peroxide
concentration  was  significantly  higher  in  subjects  with
non-complicated (p<0.05) and complicated (p<0.01) subjects
compared with non-malaria control subjects (Fig. 3a).
However, after 3 days of medication, erythrocyte lipid
peroxide level in the non-complicated malaria subjects was
restored to the same level as non-malaria control subjects. On
the other hand, lipid peroxide concentration in subjects with
complicated malaria infection remained  significantly  (p<0.05)
higher compared to non-malaria control subjects. Prior to
medication, reduced glutathione (GSH) concentration was
significantly lower in subjects with non-complicated (p<0.05)
and complicated (p<0.01) malaria compared with non-malaria
control  subjects  (Fig. 3b).  However,  following  treatment
with antimalaria drugs, GSH concentration in subjects with
complicated  malaria  infection  was  restored to the same
level observed for non-complicated malaria, but remained
significantly  (p<0.05)  lower  compared  to  that   recorded  for
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non-malaria control subjects. Erythrocyte antioxidant
enzymes, superoxide dismutase (SOD) (Fig. 3c) and catalase
(Fig. 3d) activities prior to medication and after  treatment
with  antimalarials   were  significantly  lower  (p<0.05)   in
both non-complicated and complicated  malaria  subjects
compared to  non-malaria  control  subjects. The SOD  and
catalase  activities  were  not  significantly  different  in
subjects with non-complicated malaria compared with those
with complicated malaria infection. Prior to medication,
glutathione peroxidase (GPx) activity was significantly lower
in subjects with non-complicated (p<0.05) and complicated
(p<0.01) malaria compared with non-malaria control subjects
(Fig. 3e) prior to medication. However, following antimalarial
administration, GPx activity in subjects with complicated
malaria infection was restored to the same level observed for
non-complicated malaria, but remained significantly (p<0.05)
lower compared to that recorded for non-malaria control
subjects (Fig. 3e). 
DISCUSSION
This study demonstrated that in children infected with
Plasmodium   falciparum, erythrocyte total phospholipids,
total cholesterol and LDL-cholesterol concentrations were
significantly elevated beyond normal level. This could be
attributed to the high rate of parasite multiplication in
infected erythrocytes. The positive association between
parasitemia and erythrocyte total cholesterol and
phospholipid levels further  buttresses  this claim. According
to a report by Sherman26 infected erythrocytes was
demonstrated to  contain  3-5  times  more  phospholipids
than uninfected cells during the late stage of the parasite
development. Vial and Ben Momoun3 have also shown that
the eventual survival of the  malaria parasite in the human
host is dependent on the availability of cholesterol and
phospholipids to support its growth and development. Thus,
potent inhibitors of plasmodial phospholipid synthesis were
previously characterized as potential target for antimalarial
chemotherapy due to its crucial role to the parasite survival4.
This study also showed an upsurge in erythrocyte oxidant
(lipid peroxide) status with a concomitant downregulation of
the red blood cell antioxidant status (GSH concentration and
SOD, catalase and GPx activities) in response to  P.  falciparum
infection. 
The increased production of free radical in response to
Plasmodium  falciparum  infection as observed in this study
could be a pathogenic response triggered by the parasite8 or
an adaptive response by the host to abate the infection27.
Thus, malaria infection could be viewed as a pathological
stressor. An important mechanism of action of stress is the
production of free radicals and or reactive oxygen species,
which most often react with cellular components such as;
DNA, membrane lipids, proteins and carbohydrates. These
reactive oxygen species in the cells are neutralized by
antioxidant defense system including GSH, SOD, catalase and
GPx. Thus, oxidative stress is the result of an imbalance
between oxidants and antioxidants7. Several studies have
shown that alteration of antioxidant enzyme activities in
different kinds of stress were associated with a depletion of
GSH and an increase of lipid peroxidation, all of which can lead
to oxidative stress and finally cell death1,28.
Data obtained from this study also showed that following
a three-day treatment with artemisinin combination drugs,
there was significant reduction in erythrocyte phospholipids,
total cholesterol and LDL-cholesterol concentration as well as
lipid peroxide levels. Significant augmentation in erythrocyte
antioxidant status (GSH, SOD, catalase and GPx) were also
observed after treatment with antimalarials. It has been shown
that therapeutic agents targeted at this stage of the parasite
life cycle will go a long way in preventing clinical episodes of
malaria4. The observed decrease in erythrocyte phospholipids,
total cholesterol and LDL-cholesterol following treatment with
antimalarial drugs in this study could be attributed to the
suppression of parasite growth by the drugs thus less
requirements for these lipids in membrane formation.
In the context of the present study, it is envisaged that
hyperlipidemia, which is one of the indicators of malaria
infection played a significant role in the observed  depletion
of both non-enzymic (GSH) and enzymic (SOD,  catalase  and
GPx) in the  Plasmodium  falciparum-infected erythrocyte29-31.
Lipoproteins are major lipid components in plasma and
certainly the targets for oxidative stress, thus enhancement in
the production of lipid peroxides as demonstrated by the high
MDA concentration in infected erythrocyte in this study. Thus,
findings from this study showed that  Plasmodium  falciparum
malarial infection lead to the creation of  a pro-oxidant state
(as observed in high level of MDA) and depletion of the overall
redox status in the infected red blood cell, as evident by
reduced GSH concentration and low cellular SOD, catalase and
GPx  activities.  This  pro-oxidant  environment   is   thought  to
contribute to the destruction or clearance of the parasite.
Some antimalarials such as; chloroquine acting via this
mechanism  are  reported  be  to  produce  toxic metabolites
or free radicals as intermediates when metabolized32. This
observation agrees concur with the report of  Oluba et al.33
which showed a significant increase in plasma MDA
concentration with a concomitant decrease in GSH level in
rabbits following chloroquine administration. 
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CONCLUSION
The metabolic machineries for the synthesis of
phospholipids  and  fatty  acids  have  stimulated  great
interest as potential targets for the  development  of  novel
antimalarial drugs, largely due to their importance for the
growth, proliferation and pathogenesis of plasmodium
parasites.
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